Life360 unveils $7.99 QR tags for pets

Intel (INTC) agreed to issue the U.S. government 275M shares, with up to 159M more in escrow, and warrants for 241M additional shares at $20/share if it loses majority ownership of its foundry business. Intel closed the quarter with $12.9B in cash. Its stock has high valuation metrics: forward P/E of 87, P/S of 8.3, and P/CF of 39. Intel launched the Xeon 6+ data center CPU and improved 2.5D packaging tech, EMIB T. Analysts have a consensus 'Hold' rating, with a mean target price of $113.87, sug

SpaceX plans to launch an orbital data center using Nvidia's Vera Rubin NVL72 system in Q4 2027, a year earlier than initially expected. The company will use Nvidia's chips exclusively, despite earlier plans to consider alternatives. Nvidia reported $89 billion in data center revenue last quarter, up 117% year-over-year. SpaceX is valued at over $1.8 trillion, with Nvidia as a shareholder. The success of the orbital data center depends on launch costs and radiation resistance, with test launches

SpaceX plans to launch an orbital data center powered by Nvidia's Vera Rubin NVL72 system in Q4 2027, a year earlier than initially planned. The project, in partnership with Nvidia, will use solar power and laser communication. SpaceX has decided to exclusively use Nvidia's architecture for now, but may develop its own chips later. Nvidia reported $89B in data center revenue for Q2, up 117% YoY. Launch costs and engineering challenges remain obstacles.

Chinese automakers, including Xpeng, Chery, BYD, and others, are investing in humanoid robots, following Tesla's lead. Xpeng's robotics unit raised $900M at a $6.3B valuation, with backing from founders and major investors. Xpeng's Iron robot is designed for commercial use, and the company aims to leverage its manufacturing expertise to compete with Tesla in AI.

Walmart will build a $1.3B, 1.5M sq ft automated fulfillment center in Georgia, its sixth such facility. The center will employ 1,000 workers and support ecommerce delivery. Walmart processes over 50% of ecommerce orders through automated facilities, according to the company. The center will reduce order fulfillment steps and increase productivity by 50%, per partner Knapp.

Ionis (IONS) and AstraZeneca (AZN) presented full data from a failed trial of Wainua for transthyretin amyloid cardiomyopathy (ATTR-CM). Jefferies sees neutral to negative implications for Alnylam (ALNY), which is developing similar drugs. ALNY shares closed flat, IONS down 2%, and AZN down 1% on Friday. The trial missed its primary goal, raising doubts about ALNY's TTR business.